Browse Pet Safety Reports
8,562 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 8,562 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 8,562 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Apr 1, 2017 | Dog | Bichon Frise | Trilostane | Pruritus; Crust; Hyperkeratosis; Erythema (for urticaria see Immune SOC); Der... | Euthanized |
| Mar 30, 2017 | Dog | Shepherd Dog - Australian | Imidacloprid; Moxidectin | Pruritus; Rash; Dermatitis; Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Mar 29, 2017 | Dog | Retriever - Golden | Afoxolaner 136 Mg Chewable Tablets | Behavioural disorder NOS; Hot spot (pyotraumatic dermatitis); Restlessness; A... | Outcome Unknown |
| Mar 27, 2017 | Dog | Shepherd Dog (unspecified) | Nitenpyram | Generalised itching; Hot spot (pyotraumatic dermatitis) | Ongoing |
| Mar 27, 2017 | Dog | Crossbred Canine/dog | Oclacitinib Maleate | Pyoderma; Pododermatitis | Ongoing |
| Mar 25, 2017 | Dog | Dachshund (unspecified), Do... | Oclacitinib Maleate | Dermatitis | Ongoing |
| Mar 24, 2017 | Dog | Shepherd (unspecified), Hou... | Grapiprant | Bloody diarrhoea; Preputial discharge; Skin irritation; Hot spot (pyotraumati... | Ongoing |
| Mar 21, 2017 | Cat | Siamese | Fluralaner Spot-On Solution | Application site dermatitis | Recovered/Normal |
| Mar 20, 2017 | Dog | Shepherd Dog - German | Afoxolaner 136 Mg Chewable Tablets | Pustules; Skin sore; Ulcerative dermatitis | Outcome Unknown |
| Mar 14, 2017 | Dog | Boxer (German Boxer) | Rabacfosadine Succinate | Anaemia NOS; Abnormal menace reflex test; Partial blindness; Swollen eye; Che... | Outcome Unknown |
| Mar 12, 2017 | Dog | Crossbred Canine/dog, Retri... | Fluralaner Chew Tablets | Emesis (multiple); Generalised itching; Allergic dermatitis | Ongoing |
| Mar 11, 2017 | Dog | Chihuahua | Afoxolaner | Vomiting; Pododermatitis | Recovered/Normal |
| Mar 11, 2017 | Dog | Retriever - Labrador | Deracoxib | Gastric perforation; Vomiting; Diarrhoea; Inappetence; Septicaemia; Hypoalbum... | Recovered/Normal |
| Mar 10, 2017 | Dog | Shepherd Dog - Australian | Afoxolaner | Skin lesion NOS; Pyoderma; Dermatitis | Outcome Unknown |
| Mar 8, 2017 | Dog | Retriever - Golden | Afoxolaner | Pruritus; Erythema (for urticaria see Immune SOC); Hot spot (pyotraumatic der... | Outcome Unknown |
| Mar 7, 2017 | Dog | Retriever - Golden | Spinosad; Milbemycin Oxime | Generalised itching; Hot spot (pyotraumatic dermatitis); Excessive licking an... | Outcome Unknown |
| Mar 4, 2017 | Dog | Bulldog - American | Oclacitinib Maleate | Purulent lesion(s); Elevated lipase; Elevated amylase; Other abnormal test re... | Ongoing |
| Mar 4, 2017 | Dog | Collie - Border | Afoxolaner | Pruritus; Dermatitis | Ongoing |
| Mar 3, 2017 | Dog | Retriever - Labrador | Genta/Momet/Clotrim Ear Oint | Pruritus; Scratching; Hives (see also 'Skin'); Skin scab; Purulent lesion(s);... | Ongoing |
| Mar 1, 2017 | Dog | Siberian Husky | Sarolaner | Seizure NOS; Death by euthanasia; Dermatitis | Euthanized |
| Mar 1, 2017 | Dog | Chihuahua, Maltese | Afoxolaner 68 Mg Chewable Tablets | Pruritus; Diarrhoea; Dermatitis; Enteritis; Anxiety | Outcome Unknown |
| Feb 28, 2017 | Dog | Retriever - Golden | Afoxolaner 136 Mg Chewable Tablets | Fever; Pyoderma; Skin swelling; Pododermatitis; Skin lesion NOS; Regenerative... | Outcome Unknown |
| Feb 27, 2017 | Dog | Retriever - Labrador | Trilostane | Collapse (see also 'Cardio-vascular' and 'Systemic disorders'); Swollen joint... | Ongoing |
| Feb 27, 2017 | Dog | Terrier (unspecified), Dog ... | Deracoxib | Moist dermatitis; Diarrhoea; Urinary incontinence; Pyoderma; Erythema (for ur... | Outcome Unknown |
| Feb 27, 2017 | Cat | Domestic Shorthair | Selamectin | Pruritus; Application site hair loss; General hair loss; Miliary dermatitis; ... | Ongoing |
| Feb 26, 2017 | Dog | Elkhound - Norwegian Grey | Fluralaner Chew Tablets | Dry skin; Hot spot (pyotraumatic dermatitis); Crust | Outcome Unknown |
| Feb 25, 2017 | Dog | Bichon Frise | Oclacitinib Maleate | Dyspnoea; Cyanosis; Stridor (Upper respiratory; for lower respiratory see als... | Ongoing |
| Feb 21, 2017 | Cat | Domestic Shorthair | Selamectin | Application site hair loss; Application site dermatitis; Application site red... | Ongoing |
| Feb 20, 2017 | Dog | Retriever - Golden | Fluralaner Chew Tablets | Pruritus; Pododermatitis; Dermatitis; Abnormal cytology | Ongoing |
| Feb 19, 2017 | Dog | Retriever - Golden | Phytosphingosine Salicyloyl; Chlorhex... | Rolling; Hot spot (pyotraumatic dermatitis); Itching; Anorexia | Outcome Unknown |
| Feb 18, 2017 | Cat | Domestic Mediumhair | Praziquantel; Emodepside | Application site alopecia; Alopecia general; Application site lesion; Skin le... | Recovered/Normal |
| Feb 17, 2017 | Dog | Crossbred Canine/dog | Oclacitinib Maleate | Skin scab; Skin ulcer; Vomiting; Lateral recumbency; Weakness; Respiratory tr... | Died |
| Feb 14, 2017 | Dog | Collie - Border | Oclacitinib Maleate | Lethargy (see also Central nervous system depression in 'Neurological'); Emes... | Ongoing |
| Feb 14, 2017 | Dog | Papillon - Spaniel - Contin... | Milbemcyin Oxime, Lufenuron, Praziqua... | Hot spot (pyotraumatic dermatitis); Skin slough; Skin necrosis | Recovered/Normal |
| Feb 13, 2017 | Dog | Lhasa Apso | Afoxolaner | Hot spot (pyotraumatic dermatitis) | Outcome Unknown |
| Feb 11, 2017 | Dog | Retriever (unspecified) | Cefovecin | Diabetes mellitus; Hyperglycaemia; Diabetic ketonuria; Dermatitis; Weight los... | Ongoing |
| Feb 11, 2017 | Dog | Pug | Florfenicol/Terbinafine Hydrochloride... | Erythema (for urticaria see Immune SOC); Alopecia local; Skin irritation; Swe... | Outcome Unknown |
| Feb 9, 2017 | Dog | Bulldog - French | Fluralaner Chew Tablets | Hives (see also 'Skin'); Lethargy (see also Central nervous system depression... | Outcome Unknown |
| Feb 8, 2017 | Dog | Pug | Afoxolaner 28.3 Mg Chewable Tablets | Skin disorders NOS; Allergic dermatitis; Lack of efficacy (flea) | Outcome Unknown |
| Feb 7, 2017 | Dog | Lhasa Apso | Afoxolaner 28.3 Mg Chewable Tablets | Pruritus; Dermatitis; Skin lesion NOS | Ongoing |
| Feb 7, 2017 | Dog | Lhasa Apso | Afoxolaner 28.3 Mg Chewable Tablets | Pruritus; Dermatitis; Skin lesion NOS | Ongoing |
| Feb 7, 2017 | Dog | Lhasa Apso | Afoxolaner 28.3 Mg Chewable Tablets | Pruritus; Biting -aggression (see also 'Skin and appendages disorders'); Derm... | Ongoing |
| Feb 2, 2017 | Dog | Terrier - Bull - American Pit | Oclacitinib Maleate | Dermatitis; Skin and tissue infection NOS | Ongoing |
| Feb 2, 2017 | Dog | Pit Bull | Afoxolaner | Reddening of the skin; Moist dermatitis | Outcome Unknown |
| Feb 1, 2017 | Dog | Poodle - Toy | Spinosad; Milbemycin Oxime | Vomiting; Allergic dermatitis | Ongoing |
| Feb 1, 2017 | Dog | Terrier - Bull - American Pit | Oclacitinib Maleate | Pododermatitis; Furunculosis; Erythema (for urticaria see Immune SOC); Dermat... | Ongoing |
| Feb 1, 2017 | Dog | Retriever - Labrador | Afoxolaner | Anorexia; Dermatitis; Localised hair loss | Outcome Unknown |
| Jan 31, 2017 | Dog | Terrier - Tibetan | Rabacfosadine Succinate | Anorexia; Hypercalcaemia; Elevated liver enzymes; Pyuria; Proteinuria; Elevat... | Outcome Unknown |
| Jan 30, 2017 | Dog | Shih Tzu | Carprofen | Moist dermatitis; Skin lesion NOS; Pruritus; Alopecia local | Ongoing |
| Jan 26, 2017 | Dog | Retriever - Labrador | Rabacfosadine Succinate | Vomiting; Urine abnormalities NOS; Alopecia; Otitis externa; Ulcerative derma... | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.